Clinical Trial Update: The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial update examining immunogenicity and safety of HPV vaccine co-administered with MMR vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection Type 16
• Human Papillomavirus Infection Type 18
• Measles
• Mumps
• Rubella

Drugs mentioned

• HPV vaccine
• Measles, Mumps, Rubella vaccine (Measles, Mumps, Rubella vaccine)

Snippet

Sponsor: Zhejiang Provincial Center for Disease Control and Prevention | Conditions: Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18 | Phase 4 | Status: UNKNOWN